Cargando…

Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies

Similar to other cancers, myeloid malignancies are thought to subvert the immune system during their development. This subversion occurs via both malignant cell-autonomous and non-autonomous mechanisms and involves manipulation of the innate and adaptive immune systems. Multiple strategies are being...

Descripción completa

Detalles Bibliográficos
Autores principales:	Small, Sara, Numan, Yazan, Platanias, Leonidas C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615731/ https://www.ncbi.nlm.nih.gov/pubmed/34829860 http://dx.doi.org/10.3390/biomedicines9111631

Ejemplares similares

Role of Biomarkers in the Management of Acute Myeloid Leukemia
por: Small, Sara, et al.
Publicado: (2022)

Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy
por: Lebegge, Els, et al.
Publicado: (2020)

Deregulation of Interferon Signaling in Malignant Cells
por: Katsoulidis, Efstratios, et al.
Publicado: (2010)

A novel approach to overcome drug resistance in acute myeloid leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Targeting the Innate Immune System as Immunotherapy for Acute Myeloid Leukemia
por: Curran, Emily, et al.
Publicado: (2015)

Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance
por: Eckerdt, Frank, et al.
Publicado: (2023)

Molecular Mechanisms of HIV Immune Evasion of the Innate Immune Response in Myeloid Cells
por: Mashiba, Mike, et al.
Publicado: (2012)

Exploiting innate immunity for cancer immunotherapy
por: Yi, Ming, et al.
Publicado: (2023)

Type I and II Interferons in the Anti-Tumor Immune Response
por: Fenton, Sarah E., et al.
Publicado: (2021)

Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes
por: Pesce, Silvia, et al.
Publicado: (2020)

Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy
por: Ginefra, Pierpaolo, et al.
Publicado: (2020)

PB1791: SLFN11 REGULATES MULTIPLE PATHWAYS THAT ARE IMPORTANT FOR TREATMENT RESPONSE IN AML
por: Small, Sara, et al.
Publicado: (2023)

MNK Proteins as Therapeutic Targets in Leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Nanomaterials for modulating innate immune cells in cancer immunotherapy
por: Le, Quoc-Viet, et al.
Publicado: (2019)

Immune Checkpoints and Innate Lymphoid Cells—New Avenues for Cancer Immunotherapy
por: Jacquelot, Nicolas, et al.
Publicado: (2021)

Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells
por: Gao, Xiaoqiang, et al.
Publicado: (2023)

Targeting Innate Immune Cells for Immunotherapy
por: Carreño, Leandro J., et al.
Publicado: (2017)

Innate immunity and immunotherapy for hemorrhagic shock
por: Huang, Qingxia, et al.
Publicado: (2022)

Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems
por: Manjili, Masoud H., et al.
Publicado: (2012)

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy
por: Law, Andrew M K, et al.
Publicado: (2017)

Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy
por: Khaldoyanidi, Sophia, et al.
Publicado: (2021)

Cohesin mutations in myeloid malignancies: underlying mechanisms
por: Leeke, Bryony, et al.
Publicado: (2014)

Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications
por: Farnault, Laure, et al.
Publicado: (2012)

Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy
por: Allegra, Alessandro, et al.
Publicado: (2022)

Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches
por: Gómez, Valentí, et al.
Publicado: (2020)

The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia
por: Wang, Hao, et al.
Publicado: (2018)

Myeloid cells, tissue homeostasis, and anatomical barriers as innate immune effectors in arterial hypertension
por: Wild, Johannes, et al.
Publicado: (2021)

Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity
por: Rodriguez, Paulo C., et al.
Publicado: (2017)

An aberrantly sustained emergency granulopoiesis response accelerates postchemotherapy relapse in MLL1-rearranged acute myeloid leukemia in mice
por: Wang, Hao, et al.
Publicado: (2020)

Innate Immunity Mechanisms in Marine Multicellular Organisms
por: Guryanova, Svetlana V., et al.
Publicado: (2022)

Innate immune mechanisms of mRNA vaccines
por: Verbeke, Rein, et al.
Publicado: (2022)

The mechanisms and cross-protection of trained innate immunity
por: Hu, Shiwei, et al.
Publicado: (2022)

Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies
por: Ernst, Philipp, et al.
Publicado: (2021)

Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
por: Li, Kai, et al.
Publicado: (2017)

Molecular Mechanisms and Countermeasures of Immunotherapy Resistance in Malignant Tumor
por: Jiang, Xiaoyue, et al.
Publicado: (2019)

Immunotherapy in gliomas: Are we reckoning without the innate immunity?
por: Vismara, Marco Flavio Michele, et al.
Publicado: (2019)

Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations
por: McMahon, R.A., et al.
Publicado: (2023)

Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
por: Tapia-Galisteo, Antonio, et al.
Publicado: (2023)

AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications
por: Vakana, Eliza, et al.
Publicado: (2011)

ULK1 in type I interferon response
por: Saleiro, Diana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_65l4v43pnsv13ulvbjevonqkie